# Dan Troy
ตอนพอดคาสต์ยอดนิยม
อัปเดตแล้ว:
Daniel P. Troy (born June 6, 1948 in Cleveland, Ohio) is a former Commissioner for Lake County, Ohio and a former member of the Ohio House of Representatives. In 2020, he was elected to replace the term-limited John Rogers in the Ohio House of Representatives. He will represent the 60th district seat.
Probing the Legal Arguments in the Drug Industry’s Challenges to Medicare Drug Price Negotiations
With the Biden administration’s announcement of the first 10 drugs to be negotiated for Medicare as part of the Inflation Reduction Act (IRA), an array of legal challenges from the pharmaceutical industry is potentially the biggest obstacle to implementation.
In court filings, individual drugmakers…
Deep Dive 305 - Does President Trump Have the Authority to Pause and Modify the Medicare Drug Price Negotiation Program?
Since its inception, the Inflation Reduction Act’s (IRA) Medicare Drug Price Negotiation Program has been contentiously debated. For example, several pharmaceutical manufacturers filed a lawsuit against the U.S. Department of Health and Human Services (HHS) challenging the program’s co…
Deep Dive Episode 313 - Medicare's New Drug Price Mandate: Healthcare & Innovation Implications
On January 17, the Biden-Harris Administration added 15 new drugs, including Ozempic, to the list of drugs covered by the Medicare Drug Price Negotiation Program of the Inflation Reduction Act (IRA). Now there are a total of 25 drugs that are covered by the IRA’s requirement that the Departme…
Is the FDA Trying to Ban Direct-to-Consumer Drug Ads?
The Trump Administration has been exploring new ways to tighten requirements for direct-to-consumer advertisements for prescription drugs. In its recent budget proposal, the Food and Drug Administration is asking Congress for new powers to deem drugs misbranded if they lack "fair balance" or create…
Dan Troy on the FDA, Free Speech, and the Future of Drug Innovation
In this episode of DC EKG, host Joe Grogan sits down with Dan Troy, former Chief Counsel of the FDA and a nationally recognized expert on healthcare law and the First Amendment. They explore Troy’s unique journey from free speech litigator to one of the FDA’s top legal voices, examining how the age…
Pharmaceutical Executive Daily: FDA Sends Complete Response Letter for Cingulate's CTx-1301
In today's Pharmaceutical Executive Daily, FDA has accepted a new drug application for giredestrant under priority review, FDA also issues a complete response letter for Cingulate's CTx-1301, and Dan Troy, former FDA Chief Counsel, explains the roadblocks and hurdles facing the FDA's efforts to bri…
When Pricing Pressure Reaches the FDA File: Practical FDA Realities
In this second part of our series in collaboration with White & Case and BRG, Wayne chats with Bethany Hills, Partner at White & Case, and Dan Troy, Managing Director at BRG. Together, they discuss where pricing pressures show up at FDA; how pricing issues affect how companies should think about ev…
What Lawyers Really Need To Know About Marketing
Summary Kathryn Rubino sits down with Deborah Farone, one of the most experienced legal marketing and business development advisors in the country, to dig into what actually drives sustainable practice growth. Farone traces her career from a PR firm handling Milbank's account in the 1990s through C…
Comfort Care or Hastened Death? Assisted Suicide and the Medicare Hospice Benefit
Assisted suicide is a contested issue in American law and medicine, raising questions over individual autonomy, patient rights, medical ethics, and government interests in protecting life. Federal law prohibits the use of federal funds to pay for services intended to cause or assist a death, but th…
เครื่องมือค้นหาพอดแคสต์
คุณสามารถใช้เว็บไซต์ของเราเพื่อค้นหาพอดแคสต์ของ3,825,883และตอนของ195,955,146ตามบุคคล สถานที่ หรือหัวข้อ
การลงทุนในความรู้ให้ผลตอบแทนดีที่สุด ฉันจึงฟังพอดแคสต์
‐ Benjamin "Llamacorn" Franklin
